Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? : A protocol for the MEL-SELF randomised controlled trial

Ackermann, Deonna M.Smit, Amelia K.Janda, Monikavan Kemenade, Cathelijne H.Dieng, MbathioMorton, Rachael L.Turner, Robin M.Cust, Anne E.Irwig, LesHersch, Jolyn K.Guitera, PascaleSoyer, H. PeterMar, VictoriaSaw, Robyn P.M.Low, DonaldLow, CynthiaDrabarek, DorothyEspinoza, DavidEmery, JonMurchie, PeterThompson, John F.Scolyer, Richard A.Azzi, AnthonyLilleyman, AlisterBell, Katy J.L.2021-05-262021-05-262021-05-04Ackermann, D M, Smit, A K, Janda, M, van Kemenade, C H, Dieng, M, Morton, R L, Turner, R M, Cust, A E, Irwig, L, Hersch, J K, Guitera, P, Soyer, H P, Mar, V, Saw, R P M, Low, D, Low, C, Drabarek, D, Espinoza, D, Emery, J, Murchie, P, Thompson, J F, Scolyer, R A, Azzi, A, Lilleyman, A & Bell, K J L 2021, 'Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial', Trials, vol. 22, no. 1, 324. https://doi.org/10.1186/s13063-021-05231-71745-6215ORCID: /0000-0001-9968-5991/work/95223184https://hdl.handle.net/2164/16541This research project is funded by a National Health and Medical Research Council (NHMRC) Project grant (#1163054). The funder had no role in the design of the study and will have no role in the collection, analysis, and interpretation of the data; the writing of the report; or the decision to submit the report for publication. Funding Information: AEC is funded by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC; 1147843). JFT is a recipient of an NHMRC Program Grant (1093017). RPMS is supported by Melanoma Institute Australia. RAS is supported by a NHMRC Program Grant and Practitioner Fellowship. For RAS, support from the from colleagues at Melanoma Institute Australia, Royal Prince Alfred Hospital and NSW Health Pathology is also gratefully acknowledged. RLM is supported with an NHMRC Investigator grant (1194703) and a University of Sydney Robinson Fellowship. HPS holds an NHMRC MRFF Next Generation Clinical Researchers Program Practitioner Fellowship (APP1137127). JH is supported by an NHMRC Early Career Fellowship (1112509). KB is supported by an NHMRC Investigator Grant (1174523) and a University of Sydney Research Accelerator (SOAR) Prize.182298873engSDG 3 - Good Health and Well-beingCancer surveillanceEarly detection of cancerHealth services researchMelanomaRandomised controlled trialSelf-examinationTeledermoscopyTelehealthR MedicineMedicine (miscellaneous)Pharmacology (medical)Other1147843116305410930171194703APP11371271174523Supplementary InformationRCan patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? : A protocol for the MEL-SELF randomised controlled trialJournal article10.1186/s13063-021-05231-7http://www.scopus.com/inward/record.url?scp=85105502711&partnerID=8YFLogxK221